SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI
Provided By GlobeNewswire
Last update: Dec 2, 2025
FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients
Read more at globenewswire.comNASDAQ:ICU (12/9/2025, 1:06:05 PM)
0.355
+0.02 (+4.69%)
Find more stocks in the Stock Screener
ICU Latest News and Analysis
